Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enzo Medico

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
Nature Genetics|February 24, 2015
Stromal contribution to the colorectal cancer transcriptomeClaudio Isella, Andrea Terrasi, Sara Erika Bellomo, et al.
Nature Communications|November 11, 2024
Integrative ensemble modelling of cetuximab sensitivity in colorectal cancer patient-derived xenograftsUmberto Perron, Elena Grassi, Aikaterini Chatzipli, et al.
Nature Communications|May 1, 2015
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targetsEnzo Medico, Mariangela Russo, Gabriele Picco, et al.
Genome Medicine|June 30, 2019
Evolving neoantigen profiles in colorectal cancers with DNA repair defectsGiuseppe Rospo, Annalisa Lorenzato, Nabil Amirouchene-Angelozzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2010
Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasmsRoberto Piva, Luca Agnelli, Elisa Pellegrino, et al.
ESMO Open|October 30, 2020
MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancerAnnalisa Petrelli, Sara Erika Bellomo, Ivana Sarotto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal CancerLuca Lazzari, Giorgio Corti, Gabriele Picco, et al.
British Journal of Cancer|March 12, 2024
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cellsAnxo Rio-Vilariño, Aiora Cenigaonandia-Campillo, Ana García-Bautista, et al.
Journal of Translational Medicine|October 23, 2024
Correction to: Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer CentresMatteo Pallocca, Ivan Molineris, Enrico Berrino, et al.
Journal of Translational Medicine|January 6, 2024
Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer CentresMatteo Pallocca, Ivan Molineris, Enrico Berrino, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
Nature Genetics|February 24, 2015
Stromal contribution to the colorectal cancer transcriptomeClaudio Isella, Andrea Terrasi, Sara Erika Bellomo, et al.
Nature Communications|November 11, 2024
Integrative ensemble modelling of cetuximab sensitivity in colorectal cancer patient-derived xenograftsUmberto Perron, Elena Grassi, Aikaterini Chatzipli, et al.
Nature Communications|May 1, 2015
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targetsEnzo Medico, Mariangela Russo, Gabriele Picco, et al.
Genome Medicine|June 30, 2019
Evolving neoantigen profiles in colorectal cancers with DNA repair defectsGiuseppe Rospo, Annalisa Lorenzato, Nabil Amirouchene-Angelozzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2010
Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasmsRoberto Piva, Luca Agnelli, Elisa Pellegrino, et al.
ESMO Open|October 30, 2020
MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancerAnnalisa Petrelli, Sara Erika Bellomo, Ivana Sarotto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal CancerLuca Lazzari, Giorgio Corti, Gabriele Picco, et al.
British Journal of Cancer|March 12, 2024
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cellsAnxo Rio-Vilariño, Aiora Cenigaonandia-Campillo, Ana García-Bautista, et al.
Journal of Translational Medicine|October 23, 2024
Correction to: Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer CentresMatteo Pallocca, Ivan Molineris, Enrico Berrino, et al.
Journal of Translational Medicine|January 6, 2024
Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer CentresMatteo Pallocca, Ivan Molineris, Enrico Berrino, et al.
Pageof 12